US Stock MarketDetailed Quotes
BGNE BeiGene
- 194.380
- +0.120+0.06%
Trading Nov 21 15:51 ET
20.65BMarket Cap-23589P/E (TTM)
197.480High191.410Low165.68KVolume196.090Open194.260Pre Close32.14MTurnover0.29%Turnover RatioLossP/E (Static)106.25MShares248.16052wk High6.13P/B11.12BFloat Cap126.96852wk Low--Dividend TTM57.20MShs Float426.560Historical High--Div YieldTTM3.13%Amplitude22.510Historical Low194.004Avg Price1Lot Size
About BeiGene Company
BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
Company Profile
SymbolBGNE
Company NameBeiGene
Listing DateFeb 3, 2016
Issue Price24.00
Founded2010
CEOMr. John V. Oyler
MarketNASDAQ
Employees10600
Securities TypeDR
ADS Ratio1.0 : 13.0
Fiscal Year Ends12-31
Address94 Solaris Avenue,Camana Bay,Grand Cayman
CityGeorge Town
ProvinceGeorge Town
CountryCayman Islands (the)
Zip CodeKY1-1108
Phone1-345-949-4123
Websitehttp://www.beigene.com
Company Executives
- Name
- Position
- Salary
- John V. Oyler
- Chief Executive Officer and Chairman of the Board
- 18.93M
- Dr. Xiaobin Wu, PhD
- President, Chief Operating Officer and General Manager, China
- 11.00M
- Titus B. Ball
- Principal Accounting Officer
- --
- Chan Henry Lee
- Senior Vice President, General Counsel and Assistant Secretary
- 3.04M
- Shalini Sharp
- Director
- --
- Dr. Olivier Raymond Brandicourt, M.D.
- Director
- --
- Michael J. Goller
- Independent Director
- 3.04M
- Dr. Xiaodong Wang, PhD
- Independent Director
- 4.42M
- Dr. Alessandro Riva, M.D.
- Independent Director
- 491.67K
- Qingqing Yi
- Independent Director
- 487.05K
- Anthony C. Hooper
- Independent Director
- 513.15K
- Dr. Corazon Dating Sanders, PhD
- Independent Director
- 501.55K
- Ranjeev Krishana
- Lead Independent Director
- 487.05K
- Dr. Margaret Dugan
- Independent Director
- 510.55K
- Donald W. Glazer
- Independent Director
- 480.80K
- Aaron Rosenberg
- Chief Financial Officer
- --
- Dr. Lai Wang, PhD
- Global Head of Research and Development
- 7.32M
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
